Medical/Pharmaceuticals
Innovent Announces First Patient Dosed in the Phase 2 Clinical Trial of IBI302, a First-in-class Ophthalmic Anti-VEGF and Anti-Complement Bispecific Fusion Protein for Neovascular Age-Related Macular Degeneration
SAN FRANCISCO and SUZHOU, China, April 29, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology an...
2021-04-29 08:00
5599
Essence Group Announces 'Peace of Mind' Strategy as Top Objective of All Future IoT Products and Services
HERZLIYA, Israel, April 28, 2021 /PRNewswire/ -- Essence Group
2021-04-29 07:01
2152
AnchorDx Jointly Publishes Clinical Research Paper: "Accurate Diagnosis of Pulmonary Nodules Using a Non-invasive DNA Methylation Test"
GUANGZHOU, China, April 28, 2021 /PRNewswire/ -- AnchorDx, a world-leading developer of cancer screening and early detection solutions, together with renowned thoracic experts from 14 top-tier hospitals inChina, jointly published a clinical research paper entitled "Accurate Diagnosis of Pulmonary...
2021-04-28 21:00
2330
Novaliq Announces More than 50% Patients Enrolled in CyclASol® Phase 3 Dry Eye Disease Trial ESSENCE-2
- Topline results expected in 2nd half 2021; 475 out of a 834 target patients randomized in ESSENCE-2 - Enrollment for 12-month safety extension trial (ESSENCE-2 OLE) completed - Phase 2B/3 Trial ESSENCE-1 Published in Cornea: The Journal of Cornea and External Disease HEIDELBERG, Germany and C...
2021-04-28 20:00
1929
CROs dMed and Clinipace Merge to Accelerate Customer Success
SHANGHAI and MORRISVILLE, N.C., April 28, 2021 /PRNewswire/ -- dMed Global, a full-service Clinical Contract Research Organization (CRO) based inShanghai, China, and Clinipace Incorporated, a full-service Clinical CRO with headquarters inNorth Carolina, USA, announced today that the two companies...
2021-04-28 20:00
3861
I-Mab Filed 2020 Annual Report on Form 20-F
SHANGHAI and GAITHERSBURG, Md., April 28, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the Company has filed its annual report on Form 20...
2021-04-28 20:00
2041
ERT and Bioclinica Close Merger, Creating the Global Leader in Clinical Trial Endpoint Technology
PHILADELPHIA, April 28, 2021 /PRNewswire/ -- ERT, a global leader in clinical endpoint data solutions, today announced the close of its merger withBioclinica , a technological and scientific leader in clinical imaging. This combination creates the global leader in clinical trial endpoint technolog...
2021-04-28 19:59
3141
Turn Biotechnologies completes latest round of funding
Silicon Valley investor Khosla Ventures joins esteemed group of global investors backing Turn MOUNTAIN VIEW, Calif., April 28, 2021 /PRNewswire/ -- Turn Biotechnologies, a company developing novel RNA medicines for untreatable age-related conditions, today announced that it has closed its latest...
2021-04-28 19:50
3629
Samsung Biologics Reports First Quarter 2021 Financial Results
* Q1'21 revenue of KRW 260.8 billion increased 26% compared to Q1'20. * Q1'21 operating profit of KRW 74.3 billion increased 19% compared to Q1'20. * Q1'21 operating margin held steady at 28%. * All manufacturing facilities remain fully operational, without any disruptions caused by the COV...
2021-04-28 16:37
4853
Ascensia Rolls Out The On@Pro Online Educational Platform for Healthcare Professionals in Collaboration With the Tumaini Institute
BASEL, Switzerland, April 28, 2021 /PRNewswire/ -- Ascensia Diabetes Care, a leading global diabetes care company, has announced today that it has rolled out an online educational platform for continuous personal learning aimed at healthcare professionals working with people with diabetes. The On...
2021-04-28 15:00
2026
New Distribution Facility Expands Bushu Pharma's Gateway to Asia (GTA) Services
KAWAGOE, Japan, April 28, 2021 /PRNewswire/ -- Bushu Pharmaceuticals Ltd. (hereinafter "Bushu Pharma") has established the Bushu Pharma Kazo Packaging Center located within the Kazo Pharmaceuticals Joint Distribution Center of Chuo Unyu Company ("Chuo Unyu") to carry out inspection, labeling, pac...
2021-04-28 14:00
1441
Genesis MedTech to Introduce Revolutionary Laparoscopic Technology to China and Singapore
SINGAPORE, April 28, 2021 /PRNewswire/ -- Genesis MedTech has entered a strategic distribution agreement with LivsMed, a medical device company that brings ground-breaking technology to minimally invasive surgery, for the sales and distribution of the ArtiSential™ line of products for the Chin...
2021-04-28 10:01
5370
HMI Group and Siemens Healthineers enters into strategic partnership to advance healthcare delivery in Southeast Asia
* This 5-year partnership valued over SGD 32 million, is first-of-its-kind strategic partnership for Siemens Healthineers in the region. * It focuses on upgrading HMI Group's healthcare facilities, anchoring on digitalization and enhancing local talent pool. * It includes further developme...
2021-04-28 08:05
3521
Varian and Icon Group Partner to Extend Commitment to Global Cancer Care
PALO ALTO, Calif., April 28, 2021 /PRNewswire/ -- Varian (NYSE: VAR), a Siemens Healthineers company, has signed an agreement withAustralia's Icon Group to provide 30 linear accelerators and associated treatment software to help tackle the growing global cancer burden. This agreement further stre...
2021-04-28 04:15
2665
HOYA Vision Care Releases Results of Three-Year MiYOSMART Spectacle Lens Follow-up Study
Strong evidence shows continued lens effectiveness in slowing myopia progression in children in third year BANGKOK, April 27, 2021 /PRNewswire/ -- HOYA Vision Care, a leader in optical technology innovation, shared the results of a three-year follow-up clinical study on its award winning MiYOS...
2021-04-27 21:33
3280
Rare Brain Damaged Patient May Settle Controversy Over Fish Pain
Scientists have examined rare brain damaged patients and found key areas of the brain thought to be needed for pain are not in fact necessary, undercutting a key argument used to deny pain in fish. ARLINGTON, Texas, April 27, 2021 /PRNewswire/ -- Taylor & Francis announces that a multidisciplina...
2021-04-27 20:00
1487
Holmusk Acquires Mental Health Analytics Provider Otsuka Health Solutions to Expand its Footprint in the UK
LONDON, April 27, 2021 /PRNewswire/ -- Holmusk, a leading global data science and digital health company building the world's largest Real-World Evidence (RWE) platform for behavioral health, announced today that it has acquired Otsuka Health Solutions (OHS), a UK-based mental health, predictive ...
2021-04-27 14:00
2129
Bushu Pharma's Collaboration with Suzuken Group Expands Services for Specialty Pharmaceuticals
KAWAGOE, Japan, April 27, 2021 /PRNewswire/ -- -Establishment of New Business Alliance and Facility to Provide Comprehensive Support for New Product Launches for Manufacturers Aiming to Enter Japan Market- Bushu Pharmaceuticals Ltd. (hereinafter "Bushu Pharma") has entered into a business allian...
2021-04-27 14:00
2350
MSIG partners with Singapore Cancer Society to raise public awareness on cancer risks
* Through a range of virtual seminars jointly organised with Singapore Cancer Society, MSIG will be educating its stakeholders on the topic of cancer prevention * MSIG will donate $10 for every CancerCare Plus policy sold to support SCS' cancer programmes and patient care services SINGAPORE, ...
2021-04-27 10:00
3181
DiscGenics Completes Patient Enrollment in Japanese Clinical Study of Cell Therapy for Disc Degeneration as US Study Achieves One-Year Follow-up Milestone
SALT LAKE CITY and TOKYO, April 27, 2021 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that it has c...
2021-04-27 09:23
2707
Week's Top Stories
Most Reposted
Edufrienz 99: One of Asia's First Digital Platform Advancing Character Education for Future-Ready, Compassionate Children
[Picked up by 316 media titles]
2026-01-23 11:03
UOB prices AUD2 billion in five-year senior unsecured notes
[Picked up by 305 media titles]
2026-01-23 09:00Agoda Launches Open-Source API Agent to Simplify MCP Server Integrations
[Picked up by 304 media titles]
2026-01-27 13:00
AVPN's AI Opportunity Fund Expands Regional Efforts to Build AI Skilling Infrastructure for a Future-Ready Workforce Across Asia-Pacific
[Picked up by 299 media titles]
2026-01-21 12:39Government of Telangana and Blaize Sign MoU at Davos to Launch Telangana AI Innovation Hub and Advance Applied AI Initiatives
[Picked up by 297 media titles]
2026-01-22 15:16
